ES2174132T3 - N-acil-a,omp-alquil-hidrazino-carboximidamidas. - Google Patents

N-acil-a,omp-alquil-hidrazino-carboximidamidas.

Info

Publication number
ES2174132T3
ES2174132T3 ES96945113T ES96945113T ES2174132T3 ES 2174132 T3 ES2174132 T3 ES 2174132T3 ES 96945113 T ES96945113 T ES 96945113T ES 96945113 T ES96945113 T ES 96945113T ES 2174132 T3 ES2174132 T3 ES 2174132T3
Authority
ES
Spain
Prior art keywords
carbon atoms
composition
group containing
inhibiting
hidrazino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96945113T
Other languages
English (en)
Inventor
Peter C Ulrich
Dilip R Wagle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synvista Therapeutics Inc
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/771,959 external-priority patent/US5877217A/en
Application filed by Alteon Inc filed Critical Alteon Inc
Application granted granted Critical
Publication of ES2174132T3 publication Critical patent/ES2174132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES Y METODOS QUE INHIBEN LA RETICULACION NO ENZIMATICA (ENVEJECIMIENTO DE PROTEINAS) UTILIZANDO COMPUESTOS DE FORMULA (I), DONDE ALK ES UN GRUPO ALQUILENO DE CADENA LINEAL O RAMIFICADA QUE CONTIENE ENTRE 2 Y 8 ATOMOS DE CARBONO, Y R ES UN GRUPO ALQUILO INFERIOR QUE CONTIENE ENTRE 1 Y 6 ATOMOS DE CARBONO; ASI COMO SUS SALES DE ADICION BIOLOGICA O FARMACEUTICAMENTE ACEPTABLES. CONSECUENTEMENTE, SE DESCRIBE UNA COMPOSICION QUE COMPRENDE DICHAS N ACILAMINOALQUILHIDRAZINCARBOXIMIDAMIDAS, QUE SON CAPACES DE INHIBIR LA FORMACION DE PRODUCTOS FINALES DE GLICOSILACION AVANZADA DE PROTEINAS DIANA. DICHO METODO CONSISTE EN PONER EN CONTACTO LA PROTEINA DIANA CON DICHA COMPOSICION. SE PREVEN APLICACIONES TANTO INDUSTRIALES COMO TERAPEUTICAS PARA LA INVENCION, COMO EL TRATAMIENTO DE LA DEGRADACION DE ALIMENTOS Y EL ENVEJECIMIENTO DE PROTEINAS ANIMALES.
ES96945113T 1995-12-26 1996-12-26 N-acil-a,omp-alquil-hidrazino-carboximidamidas. Expired - Lifetime ES2174132T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US922095P 1995-12-26 1995-12-26
US61840796A 1996-03-19 1996-03-19
US08/771,959 US5877217A (en) 1995-12-26 1996-12-23 N-acylaminoalkyl-hydrazinecarboximidamides

Publications (1)

Publication Number Publication Date
ES2174132T3 true ES2174132T3 (es) 2002-11-01

Family

ID=27358809

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96945113T Expired - Lifetime ES2174132T3 (es) 1995-12-26 1996-12-26 N-acil-a,omp-alquil-hidrazino-carboximidamidas.

Country Status (15)

Country Link
EP (1) EP0888293B1 (es)
JP (1) JP2000502684A (es)
CN (1) CN1209117A (es)
AT (1) ATE215068T1 (es)
AU (1) AU720796B2 (es)
BR (1) BR9612304A (es)
CA (1) CA2241746A1 (es)
DE (1) DE69620253T2 (es)
DK (1) DK0888293T3 (es)
ES (1) ES2174132T3 (es)
NO (1) NO982976L (es)
NZ (1) NZ326238A (es)
PT (1) PT888293E (es)
TW (1) TW502012B (es)
WO (1) WO1997023447A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
BRPI0711558A2 (pt) 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
MX341025B (es) 2010-05-05 2016-08-04 Boehringer Ingelheim Int Gmbh * Terapia de combinacion.
PH12012502524A1 (en) 2010-06-24 2014-02-10 Boehringer Ingelheim Int Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging

Also Published As

Publication number Publication date
WO1997023447A1 (en) 1997-07-03
CN1209117A (zh) 1999-02-24
NO982976L (no) 1998-08-26
DE69620253T2 (de) 2002-09-19
TW502012B (en) 2002-09-11
BR9612304A (pt) 1999-07-13
CA2241746A1 (en) 1997-07-03
PT888293E (pt) 2002-07-31
DE69620253D1 (en) 2002-05-02
EP0888293B1 (en) 2002-03-27
DK0888293T3 (da) 2002-04-22
ATE215068T1 (de) 2002-04-15
NO982976D0 (no) 1998-06-26
AU1356097A (en) 1997-07-17
NZ326238A (en) 1999-11-29
EP0888293A1 (en) 1999-01-07
AU720796B2 (en) 2000-06-15
JP2000502684A (ja) 2000-03-07

Similar Documents

Publication Publication Date Title
DK0888293T3 (da) N-acylaminoalkylhydrazin-carboximidamider
ATE112165T1 (de) Verfahren und mittel zur hemmung des proteinveraltens.
WO1993014750A3 (en) Amino acids useful as inhibitors of the advanced glycosylation of proteins
NZ312840A (en) Ketoheterocyclic inhibitors of factor Xa
RU94046457A (ru) Производные аспартама, способ их получения и содержащее их подслащивающее средство
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
EA200000871A1 (ru) Ингибиторы фосфолипазных ферментов
EP0316852A3 (en) Inhibitors of nonenzymatic cross-linking
ATE59296T1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
RU97105363A (ru) Жидкие иммуноглобулиновые препараты
MY135057A (en) Dolastatin 15 derivatives
EA199800773A1 (ru) Производные пирролопирролона в качестве ингибиторов нейтрофильной эластазы
EA199800378A1 (ru) Новый способ получения фенилимидазолидиновых производных
AU3895689A (en) Cyclic sulfur-containing amino acid derivatives
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
WO1996021450A3 (en) Bis-[hydrazones]
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
DE69718775D1 (de) 1,2,4-triazinderivate zur inhibierung der proteinglycosylierung
AU2825897A (en) Substituted imidazolium salts and their use for the inhibition of protein ageing
WO1997042175B1 (en) Substituted imidazolium salts and their use for the inhibition of protein ageing
RU95117692A (ru) Щелочные соли амидов оротовой кислоты и аминокислот, обладающие гипертензивной активностью
BR9604914A (pt) Inibidores de agregaçao de plaquetas contendo resíduos de aminoácido de cadeia lateral aminérgicos c-terminais
DE69622393D1 (de) Neue verwendung von pyrazolopyridinverbindungen
KR910018021A (ko) 단백질의 글리코실화 진행 억제제 및 그 이용 방법
RU94035756A (ru) Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 888293

Country of ref document: ES